The European venture firm raised 500 million euros, or about $579 million, for its latest fund, which follows a flurry of ...
Medicxi, a leading European life sciences venture capital firm, today announced the closing of Medicxi V, a €500 million fund dedicated to building and backing innovative biotechnology companies with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback